Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:I-121-I-126
doi: 10.1161/CIRCULATIONAHA.106.680249
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buerke, M.
Right arrow Articles by Werdan, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buerke, M.
Right arrow Articles by Werdan, K.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Acute myocardial infarction
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Apoptosis
Right arrow CV surgery: coronary artery disease
Right arrow Cell signalling/signal transduction
Right arrow Ischemic biology - basic studies
Right arrow Physiological and pathological control of gene expression

(Circulation. 2007;116:I-121 – I-126.)
© 2007 American Heart Association, Inc.


Myocardial Protection, Perioperative Management, and Vascular Biology

Effects of Aprotinin on Gene Expression and Protein Synthesis After Ischemia and Reperfusion in Rats

Michael Buerke, MD; Diethard Pruefer, MD; Dennis Sankat; Justin M. Carter, MRCP; Ute Buerke, MD; Martin Russ, MD; Axel Schlitt, MD; Ivar Friedrich, MD; Jochen Börgermann, MD; Christian F. Vahl, MD; Karl Werdan, MD

From the Department of Internal Medicine III (M.B., D.S., J.M.C., U.B., M.R., A.S., K.W.), Martin Luther University Halle-Wittenberg, Halle/Saale, Germany; Department of Cardio-Thoracic and Vascular Surgery (D.P., C.F.V.), Johannes-Gutenberg University Mainz, Mainz, Germany; Department of Cardio-Thoracic-Surgery (I.F., J.B.), Martin Luther University Halle-Wittenberg, Halle/Saale, Germany.

Correspondence to Michael Buerke, MD, Department of Internal Medicine III, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle/Saale, Germany. E-mail michael.buerke{at}medizin.uni-halle.de

Background— Reperfusion injury of ischemic myocardium has been attributed to neutrophil infiltration, inflammatory activation and cardiac necrosis/apoptosis. Serine protease inhibition with aprotinin is cardioprotective, but the mechanism is unknown.

Methods and Results— We studied aprotinin in a rat model of myocardial ischemia for 20 minutes and reperfusion for 20 minutes, 8 hours or 24 hours. Aprotinin (20 000 IU/kg) given 5 minutes before reperfusion significantly reduced leukocyte accumulation (P<0.01), myocardial injury (determined by CK depletion, P<0.01) and myocyte apoptosis (P<0.05) compared with vehicle treated rats. Differential gene expression analysis showed myocardial ischemia plus reperfusion increased expression of proinflammatory genes like P-selectin, E-selectin, intercellular adhesion molecule, tumor necrosis factor-{alpha}, tumor necrosis factor-{alpha} receptor, interleukin-6, monocyte chemoattractant protein-1, p53, and Fas (CD59). Aprotinin before reperfusion suppressed expression of these inflammatory genes. Finally, differential protein expression analysis demonstrated increased intercellular adhesion molecule-1, tumor necrosis factor-{alpha}, and p53 after myocardial ischemia plus reperfusion, and this effect was diminished by aprotinin.

Conclusions— We demonstrated myocardial ischemia plus reperfusion induced leukocyte accumulation, inflammation, gene expression, protein expression and finally tissue injury and showed aprotinin limiting reperfusion injury through each of these stages, even after 24 hours of reperfusion. This effect seems partly attributable to suppression of proinflammatory genes and leukocyte accumulation. This work casts further light on the complex signaling of ischemia and reperfusion.


Key Words: ischemia-reperfusion injury • leukocytes • gene expression profiling • protein synthesis